Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials
European Heart Journal2020Vol. 41(34), pp. 3228–3235
Citations Over TimeTop 1% of 2020 papers
Yousif Ahmad, James P. Howard, Ahran Arnold, Christopher Cook, Megha Prasad, Ziad A. Ali, Manish A. Parikh, Ioanna Kosmidou, Dárrel P. Francis, Jeffrey W. Moses, Martin B. Leon, Ajay J. Kirtane, Gregg W. Stone, Dimitri Karmpaliotis
Abstract
The totality of randomized clinical trial evidence demonstrated similar long-term mortality after PCI with DES compared with CABG in patients with LMCAD. Nor were there significant differences in cardiac death, stroke, or MI between PCI and CABG. Unplanned revascularization procedures were less common after CABG compared with PCI. These findings may inform clinical decision-making between cardiologists, surgeons, and patients with LMCAD.
Related Papers
- → Effects of Eight Weeks of Cardiac Rehabilitation Training on Serum Levels of Sirtuin1 and Functional Capacity of Post- Coronary Artery Bypass Grafting Patients(2019)4 cited
- → Long Term Health Outcomes Following Coronary Artery Bypass Grafting: A Different Journey for Men and Women(2019)2 cited
- Progress in Coronary Artery Bypass Grafting(2004)
- → Faculty Opinions recommendation of Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program).(2010)
- → Faculty Opinions recommendation of Effects of Blood Transfusion on Cause-Specific Late Mortality After Coronary Artery Bypass Grafting-Less Is More.(2017)